fda semaglutide warning september 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" FDA Adds New Warnings to

Carnitine as a slimming agent The belief that carnitine is a slimming agent is based on the assumption that regular oral ingestion of carnitine increases the muscle carnitine concentration

Although these drugs have been used to treat type 2 diabetes for nearly two decades, it was not until 2021 that the US FDA approved them for treating obesity

When you give attention to both medicine and daily habit changes, people get better results

Governor Gavin Newsom of California just proposed eliminating Medicaid coverage for GLP-1 weight loss drugs

Liver Fat Reduction: Clinical data showed substantial reductions in liver fat levels among participants with fatty liver disease